SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros is trending as investors react to a significant revenue beat in Q2 and the successful repayment of convertible debt, leading to increased bullish sentiment and discussions around a potential short squeeze. Community members are focusing on Yartemlea's commercial ramp-up, upcoming Medicare reimbursement catalysts, and the company's progress toward achieving long-term profitability.

Intuit, Inc. engages in the provision of business and financial management solutions. It operates through the following segments: Small Business and Self-Employed, Consumer, Credit Karma, and ProTax. The Small Business and Self-Employed segment offers QuickBooks financial and business management online services and desktop software, payroll solutions, payment processing solutions, and financing for small businesses. The Consumer segment includes do-it-yourself and assisted TurboTax income tax preparation products and services. The Credit Karma segment serves consumers with a personal finance platform that provides personalized recommendations of credit cards, home, auto and personal loans, and insurance products, and online savings and checking accounts. The ProTax segment refers to the professional accountants in the U.S. and Canada, who are essential to both small business success and tax preparation and filing. The company was founded by Scott D. Cook and Thomas A. Proulx in March 1983 and is headquartered in Mountain View, CA.

Intuit Inc

Intuit is trending as investors weigh recovery potential against ongoing concerns that AI-powered tools could disrupt its core software products ahead of upcoming earnings. While retail sentiment remains mixed, many in the community are debating whether the recent selloff represents a deep-value opportunity or a signal of structural weakness in the company's long-term growth.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is under pressure as rising Treasury yields and stubborn inflation concerns drive investors away from long-duration bonds. The community is actively discussing the potential for a deeper decline toward support levels amid worries about the U.S. debt burden and ongoing geopolitical tensions.

Kopin Corp. engages in the development, manufacture and sale of wearable technologies which include components and systems. Its portfolio includes AMLCD, LCOS displays, OLED displays, ASIC, backlights, and optical lenses. The firm uses semiconductor material technology to design, manufacture and market its component products for use in military, enterprise and consumer electronic applications, training and simulation equipment and 3D metrology equipment. The company was founded by John C.C. Fan on April 23, 1984 and is headquartered in Westborough, MA.

Kopin Corp.

Kopin Corp

Kopin Corp is trending as investors monitor its involvement in defense-related optical technologies and its strategic pivot toward AI infrastructure through the development of MicroLED optical interconnects. Community sentiment remains polarized between long-term holders focused on potential defense contracts and new tech partnerships, and those frustrated by the stock's volatility and recent downward price action.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Investors are actively debating Cipher's valuation and volatility, with many characterizing the stock's recent sharp downward swings as liquidity-driven manipulation or institutional rebalancing rather than fundamental weakness. While some express frustration with its decoupling from Bitcoin trends, others are treating the dip as a long-term accumulation opportunity, pointing to the company's progress in expanding high-performance computing infrastructure and pending regulatory clarity in Texas.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as retail investors speculate on the timing of a critical 80th clinical event in its REGAL Phase 3 AML trial, fueling heated debates over clinical data versus market sentiment. The community is divided between bullish anticipation of curative potential for the GPS candidate and skeptical scrutiny regarding the trial's timeline and underlying research claims.

First Solar, Inc. is a solar technology company, which engages in the provision of solar modules. It is involved in the design, manufacture, and sale of cadmium tellurid (CdTe) solar modules, which convert sunlight into electricity. The company was founded by Michael J. Ahearn in 1999 and is headquartered in Phoenix, AZ.

First Solar Inc

First Solar is trending as investors weigh potential market shifts from proposed polysilicon tariffs and domestic manufacturing incentives against broader semiconductor and utility-scale energy demand. The community is actively debating the company's valuation relative to its growth, navigating recent class-action litigation news, and analyzing whether current price levels offer a strong entry point for a long-term energy infrastructure play.

XPeng, Inc. engages in the design, development, manufacture, and marketing of smart electric vehicles. Its products are environmentally friendly vehicles, namely an SUV (the G3) and a four-door sports sedan (the P7). It also provides a range of services to the clients, including supercharging service, maintenance service, ride-hailing service and vehicle leasing service. The company was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

Investors are actively weighing XPEV's growth in EV sales and robotics against the broader downward pressure on Chinese stocks, with sentiment divided on whether current valuations offer a deep-value opportunity ahead of upcoming earnings. Community discussions focus on the company's autonomous driving technology, the upcoming launch of new models, and the aggressive expansion of its physical AI and humanoid robot initiatives as key long-term catalysts.

Anthropic

Anthropic is trending as it prepares for an anticipated mega-IPO, with community members closely tracking the company's record-breaking valuation, expansion of its massive AI infrastructure, and competition with OpenAI. Discussions are dominated by speculation on IPO timing, the potential market impact of such a large public debut, and Anthropic's strategic shift toward aggressive enterprise revenue growth.

OpenAI

OpenAI is trending as the community debates its long-term IPO prospects, recent executive turnover, and the company's ambitious, capital-intensive infrastructure plans. Discussion is heavily focused on competition with Anthropic and concerns regarding the sustainability of the massive data center spending required to maintain its market position.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Kiromic Biopharma, Inc. is a clinical stage biotherapeutics company, which engages in DIAMOND AI and discovers, validates, and develops cell and gene therapies with a therapeutic focus on immuno-oncology. The firm is in the process of developing ALEXIS, a multi-indication allogeneic CAR-T cell therapy platform that exploits the natural potency of gamma delta T-cells to target solid cancers. The company was founded by Maurizio Chiriva-Internati and Scott Dahlbeck on August 6, 2006 and is headquartered in Houston, TX.

Kiromic BioPharma Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

KRBP Kiromic BioPharma Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest KRBP News